Health Invest Partners Ab Mersana Therapeutics, Inc. Transaction History
Health Invest Partners Ab
- $208 Million
- Q4 2024
A detailed history of Health Invest Partners Ab transactions in Mersana Therapeutics, Inc. stock. As of the latest transaction made, Health Invest Partners Ab holds 538,621 shares of MRSN stock, worth $177,744. This represents 0.37% of its overall portfolio holdings.
Number of Shares
538,621
Previous 538,621
-0.0%
Holding current value
$177,744
Previous $1.02 Million
24.29%
% of portfolio
0.37%
Previous 0.49%
Shares
3 transactions
Others Institutions Holding MRSN
# of Institutions
138Shares Held
101MCall Options Held
77.2KPut Options Held
453K-
Nextech Invest Ag12.1MShares$3.98 Million3.22% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.3MShares$3.74 Million0.76% of portfolio
-
Vr Adviser, LLC New York, NY10.3MShares$3.39 Million2.42% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA8.66MShares$2.86 Million3.35% of portfolio
-
Black Rock Inc. New York, NY8.38MShares$2.77 Million0.0% of portfolio
About Mersana Therapeutics, Inc.
- Ticker MRSN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 97,169,296
- Market Cap $32.1M
- Description
- Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...